Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin

BackgroundExtracellular matrix (ECM) is an integral player in the pathophysiology of a variety of cardiac diseases. Cardiac ECM is composed mainly of collagen, of which type 1 is the most abundant with procollagen type 1 N-terminal Propeptide (P1NP) as a formation marker. P1NP is associated with mor...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas Andersen, Thor Ueland, Pål Aukrust, Dennis W.T. Nilsen, Heidi Grundt, Harry Staines, Volker Pönitz, Frederic Kontny
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1191055/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849423468510052352
author Thomas Andersen
Thomas Andersen
Thor Ueland
Thor Ueland
Thor Ueland
Pål Aukrust
Pål Aukrust
Pål Aukrust
Dennis W.T. Nilsen
Dennis W.T. Nilsen
Heidi Grundt
Heidi Grundt
Harry Staines
Volker Pönitz
Frederic Kontny
Frederic Kontny
author_facet Thomas Andersen
Thomas Andersen
Thor Ueland
Thor Ueland
Thor Ueland
Pål Aukrust
Pål Aukrust
Pål Aukrust
Dennis W.T. Nilsen
Dennis W.T. Nilsen
Heidi Grundt
Heidi Grundt
Harry Staines
Volker Pönitz
Frederic Kontny
Frederic Kontny
author_sort Thomas Andersen
collection DOAJ
description BackgroundExtracellular matrix (ECM) is an integral player in the pathophysiology of a variety of cardiac diseases. Cardiac ECM is composed mainly of collagen, of which type 1 is the most abundant with procollagen type 1 N-terminal Propeptide (P1NP) as a formation marker. P1NP is associated with mortality in the general population, however, its role in myocardial infarction (MI) is still uncertain, and P1NP has not been investigated in acute chest pain. The objective of the current study was to assess the role of P1NP in undifferentiated acute chest pain of suspected coronary origin.Methods and results813 patients from the Risk in Acute Coronary Syndromes study were included. This was a single-center study investigating biomarkers in consecutively enrolled patients with acute chest pain of suspected coronary origin, with a follow-up for up to 7 years. Outcome measures were a composite endpoint of all-cause death, new MI or stroke, as well as its individual components at 1, 2, and 7 years, and cardiac death at 1 and 2 years. In multivariable Cox regression analysis, quartiles of P1NP were significantly associated with the composite endpoint at 1 year of follow-up with a hazard ratio for Q4 of 1.82 (95% CI, 1.12–2.98). There was no other significant association with outcomes at any time points.ConclusionP1NP was found to be an independent biomarker significantly associated with adverse clinical outcome at one year in patients admitted to hospital for acute chest pain of suspected coronary origin. This is the first report in the literature on the prognostic value of P1NP in this clinical setting.Clinicaltrials.ygov IdentifierNCT00521976.
format Article
id doaj-art-da722ff5ed9a4d04a696e5f84b6e3412
institution Kabale University
issn 2297-055X
language English
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-da722ff5ed9a4d04a696e5f84b6e34122025-08-20T03:30:35ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-09-011010.3389/fcvm.2023.11910551191055Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary originThomas Andersen0Thomas Andersen1Thor Ueland2Thor Ueland3Thor Ueland4Pål Aukrust5Pål Aukrust6Pål Aukrust7Dennis W.T. Nilsen8Dennis W.T. Nilsen9Heidi Grundt10Heidi Grundt11Harry Staines12Volker Pönitz13Frederic Kontny14Frederic Kontny15Department of Anesthesiology, Stavanger University Hospital, Stavanger, NorwayDepartment of Clinical Science (K2), University of Bergen, Bergen, NorwayResearch Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, NorwayThrombosis Research Centre (TREC), Department of Clinical Medicine, UiT—The Arctic University of Norway, Tromsø, NorwayInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayResearch Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, NorwayInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwaySection of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, NorwayDepartment of Cardiology, Stavanger University Hospital, Stavanger, NorwayDepartment of Clinical Science, University of Bergen, Bergen, NorwayDepartment of Clinical Science, University of Bergen, Bergen, NorwayDepartment of Pulmonology, Stavanger University Hospital, Stavanger, Norway0Sigma Statistical Services, Balmullo, United KingdomDepartment of Cardiology, Stavanger University Hospital, Stavanger, NorwayDepartment of Cardiology, Stavanger University Hospital, Stavanger, Norway1Drammen Heart Centre, Drammen, NorwayBackgroundExtracellular matrix (ECM) is an integral player in the pathophysiology of a variety of cardiac diseases. Cardiac ECM is composed mainly of collagen, of which type 1 is the most abundant with procollagen type 1 N-terminal Propeptide (P1NP) as a formation marker. P1NP is associated with mortality in the general population, however, its role in myocardial infarction (MI) is still uncertain, and P1NP has not been investigated in acute chest pain. The objective of the current study was to assess the role of P1NP in undifferentiated acute chest pain of suspected coronary origin.Methods and results813 patients from the Risk in Acute Coronary Syndromes study were included. This was a single-center study investigating biomarkers in consecutively enrolled patients with acute chest pain of suspected coronary origin, with a follow-up for up to 7 years. Outcome measures were a composite endpoint of all-cause death, new MI or stroke, as well as its individual components at 1, 2, and 7 years, and cardiac death at 1 and 2 years. In multivariable Cox regression analysis, quartiles of P1NP were significantly associated with the composite endpoint at 1 year of follow-up with a hazard ratio for Q4 of 1.82 (95% CI, 1.12–2.98). There was no other significant association with outcomes at any time points.ConclusionP1NP was found to be an independent biomarker significantly associated with adverse clinical outcome at one year in patients admitted to hospital for acute chest pain of suspected coronary origin. This is the first report in the literature on the prognostic value of P1NP in this clinical setting.Clinicaltrials.ygov IdentifierNCT00521976.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1191055/fullbiomarkersacute coronary syndromesmortality/survivalrisk factorsextracellular matrixcollagen
spellingShingle Thomas Andersen
Thomas Andersen
Thor Ueland
Thor Ueland
Thor Ueland
Pål Aukrust
Pål Aukrust
Pål Aukrust
Dennis W.T. Nilsen
Dennis W.T. Nilsen
Heidi Grundt
Heidi Grundt
Harry Staines
Volker Pönitz
Frederic Kontny
Frederic Kontny
Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
Frontiers in Cardiovascular Medicine
biomarkers
acute coronary syndromes
mortality/survival
risk factors
extracellular matrix
collagen
title Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
title_full Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
title_fullStr Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
title_full_unstemmed Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
title_short Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
title_sort procollagen type 1 n terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
topic biomarkers
acute coronary syndromes
mortality/survival
risk factors
extracellular matrix
collagen
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1191055/full
work_keys_str_mv AT thomasandersen procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT thomasandersen procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT thorueland procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT thorueland procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT thorueland procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT palaukrust procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT palaukrust procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT palaukrust procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT denniswtnilsen procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT denniswtnilsen procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT heidigrundt procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT heidigrundt procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT harrystaines procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT volkerponitz procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT frederickontny procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin
AT frederickontny procollagentype1nterminalpropeptideisassociatedwithadverseoutcomeinacutechestpainofsuspectedcoronaryorigin